ST Pharm Co.Ltd(237690)

Description: ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.

---

Keywords: Life Sciences Molecular Biology Asthma Cough Hepatitis B MRI Epilepsy Erectile Dysfunction Diabetes Mellitus Validation Copd Oligonucleotide Nucleic Acids Small Interfering Rna Aptamer Si RNA

---

Home Page: www.stpharm.co.kr

MSA Building
Seoul, 06194
South Korea
Phone: 82 2 527 6373

---

Officers

Exchange: KQ

Country: KR

Currency: Korean Won (₩)